Large-scale testing (Phase 3)Ended earlyNCT04931667
What this trial is testing
3-year, Open-Label Study Evaluating Safety, Tolerability, and Efficacy of Lorecivivint in Subjects With Osteoarthritis of the Knee
Who this might be right for
Osteoarthritis of the Knee
Biosplice Therapeutics, Inc. 73